Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The Dual Role of PAI-1 Mutations in Bleeding and Thrombotic Disorders – ICHCC
ICHCC/LinkedIn
May 25, 2026, 05:07

The Dual Role of PAI-1 Mutations in Bleeding and Thrombotic Disorders – ICHCC

Iranian Comprehensive Hemophilia Care Center (ICHCC) shared a post on LinkedIn:

“PAI-1 Mutation versus PAI-1 Deficiency — Clinical Differences:

Plasminogen Activator Inhibitor-1 (PAI-1) is a key regulator of the fibrinolytic system and controls the activity of tPA and uPA.

Although the terms PAI-1 mutation and PAI-1 deficiency are sometimes used interchangeably, they can present very differently clinically.

What is PAI-1 Deficiency?

PAI-1 deficiency is a rare inherited bleeding disorder caused by markedly reduced or absent PAI-1 activity.

Main Clinical Features:

  • Delayed bleeding after trauma or surgery
  • Menorrhagia
  • Epistaxis
  • Postpartum hemorrhage
  • Excessive fibrinolysis with unstable clot formation

Patients usually have normal coagulation tests but increased fibrinolytic activity.

What does ‘PAI-1 mutation’ mean?

A PAI-1 mutation may lead to: 

  • low function (loss-of-function)
  • high expression/activity (gain-of-function)
  • altered regulation of fibrinolysis

Therefore, not all PAI-1 mutations cause bleeding.

Clinical Difference

PAI-1 Deficiency usually presents with:

  • Bleeding tendency
  • Hyperfibrinolysis
  • Poor clot stability

Certain PAI-1 Mutations May instead be associated with:

  • Thrombotic tendency
  • Increased fibrosis
  • Cardiovascular risk
  • Metabolic syndrome (in some polymorphisms)

Example:

The 4G/5G polymorphism can influence PAI-1 expression and thrombosis risk.

Key Concept

PAI-1 deficiency equals absence/reduction of inhibitor – excessive fibrinolysis – bleeding

Some PAI-1 mutations equals excess inhibitor activity – impaired fibrinolysis – thrombosis

Take-home Message

Not every PAI-1 mutation behaves like true PAI-1 deficiency.

The clinical presentation depends on whether the mutation decreases or increases PAI-1.”

The Dual Role of PAI-1 Mutations in Bleeding and Thrombotic Disorders - ICHCC

Stay updated with Hemostasis Today.

Health Hematology Hemostasis Hemostasis News Hemostasis Today ICHCC Iranian Comprehensive Hemophilia Care Center Medicine PAI-1 Deficiency PAI-1 Mutation
NewsFeed